All data are based on the daily closing price as of November 11, 2026
a
Alfresa Holdings
2784.TSE
13.80 USD
-0.25
-1.78%
Overview
Last close
13.80 usd
Market cap
2.42B usd
52 week high
17.15 usd
52 week low
13.19 usd
Target price
14.44 usd
Valuation
P/E
10.4433
Forward P/E
10.0301
Price/Sales
0.1234
Price/Book Value
0.8
Enterprise Value
1.43B usd
EV/Revenue
0.0718
EV/EBITDA
3.0192
Key financials
Revenue TTM
19.87B usd
Gross Profit TTM
1.37B usd
EBITDA TTM
303.54M usd
Earnings per Share
1.34 usd
Dividend
0.21 usd
Total assets
9.29B usd
Net debt
-996.94M usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products; and engages in insurance agency, real estate management, and sales of daily necessities and consumables activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Chiyoda, Japan.